Antares Pharma (ATRS) Reports In-Line Q1 Loss of 3c/Share
Tweet Send to a Friend
Antares Pharma (NASDAQ: ATRS) reported Q1 EPS of ($0.03) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
